Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Medicine (Baltimore). 2023 Jun 2;102(22):e33897. doi: 10.1097/MD.0000000000033897.
Medicine (Baltimore). 2023.
PMID: 37266631
Free PMC article.
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group.
Ciaffi L, et al. Among authors: mbouyap pr.
Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.
Lancet HIV. 2017.
PMID: 28566227
Clinical Trial.
Item in Clipboard
Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP.
Galy A, Ciaffi L, Mberyo GM, Mbouyap P, Abessolo H, Toby R, Essomba F, Lamarre G, Bikié A, Bell O, Koulla-Shiro S, Delaporte E.
Galy A, et al.
Patient Educ Couns. 2018 Jul;101(7):1262-1269. doi: 10.1016/j.pec.2018.01.021. Epub 2018 Feb 1.
Patient Educ Couns. 2018.
PMID: 29433950
Item in Clipboard
Cite
Cite